Zinc Pyrithione (ZPT)
| Min. Order: | 30 kg |
|---|---|
| Port: | Shanghai, China |
| Transport Package: | Fiber Drum |
| Payment Terms: | L/C |
Product Description
Company Info
Address:
36 Shuanggao Road, Gaochun Development Zone, Nanjing, Jiangsu, China
Business Type:
Manufacturer/Factory
Business Range:
Health & Medicine
Management System Certification:
ISO 9001, ISO 14001, GMP
Main Products:
API, API Intermediates, DC, Pellets, Pyridine Derivatives
Company Introduction:
Jiangsu Zhongbang Pharmaceutical Co., Ltd. Is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100, 000m2. Company has 48 million RMB registered capital and plan to have a total investment of 200 million RMB.
Company has 168 employees at present, in which there are 34 employees with Bachelor′s Degree or above, 12 employees with Master′s Degree or above, each kind of professional talents have occupied over 60% of the total employees.
Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products.
Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.
Company has 168 employees at present, in which there are 34 employees with Bachelor′s Degree or above, 12 employees with Master′s Degree or above, each kind of professional talents have occupied over 60% of the total employees.
Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products.
Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.
